Report overview
Targeted Drug Delivery Device is a method of delivery medication in some parts of the body. This means of delivery is largely founded on nanomedicine, which plans to employ nanoparticle-mediated drug delivery in order to combat the downfalls of conventional drug delivery. These nanoparticles would be loaded with drugs and targeted to specific parts where there is solely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of the Targeted Drug Delivery is to prolong, localize, target and have a protected drug interaction with the diseased tissue. The conventional drug delivery system is the absorption of the drug across a biological membrane, whereas the targeted release system releases the drug in a dosage form. The advantages to the targeted release system is the reduction in the frequency of the dosages taken by the patient, having a more uniform effect of the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes productivity more difficult and the reduced ability to adjust the dosages. (Wikipedia)
This report aims to provide a comprehensive presentation of the global market for Targeted Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Drug Delivery Device. This report contains market size and forecasts of Targeted Drug Delivery Device in global, including the following market information:
Global Targeted Drug Delivery Device Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Targeted Drug Delivery Device market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
by Target Organ Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Targeted Drug Delivery Device include 4D Molecular Therapeutics, AbbVie, Abeona Therapeutics, Advaxis, Alcyone Lifesciences, AlphaVax, Amgen, Amicus Therapeutics and Anaeropharma Science, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Targeted Drug Delivery Device companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeted Drug Delivery Device Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Targeted Drug Delivery Device Market Segment Percentages, by Type, 2022 (%)
by Target Organ
Eye
Brain
Heart
Breast
Abdomen
Others
by Type of Biologic Delivered
Cell
Protein
Enzyme
Plasmid
Antibody
Small Peptide
Modified RNA
Growth Factor
Neurotransmitter
by Therapy Delivered
Cell Therapy
RNA Therapy
Gene Therapy
Immunotherapy
Stem Cell Therapy
Global Targeted Drug Delivery Device Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Targeted Drug Delivery Device Market Segment Percentages, by Application, 2022 (%)
Metabolic Disorder
Ophthalmic Disease
Oncological Disorder
Neurological Disorder
Cardiovascular Disorder
Others
Global Targeted Drug Delivery Device Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Targeted Drug Delivery Device Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeted Drug Delivery Device revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Targeted Drug Delivery Device revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
4D Molecular Therapeutics
AbbVie
Abeona Therapeutics
Advaxis
Alcyone Lifesciences
AlphaVax
Amgen
Amicus Therapeutics
Anaeropharma Science
AnGes
AskBio
Astellas Pharma
AstraZeneca
Athersys
BioCardia
Biogen
BioInvent
BioRestorative Therapies
bluebird bio
Boston Scientific
CellProthera
Celsion
Celyad
Evonik
Kadimastem
Medtronic
Novartis
Sanofi
SOTIO
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Targeted Drug Delivery Device, market overview.
Chapter 2: Global Targeted Drug Delivery Device market size in revenue.
Chapter 3: Detailed analysis of Targeted Drug Delivery Device company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Targeted Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
